PHOTRONICS INC (PLAB) Stock Fundamental Analysis
NASDAQ:PLAB - Nasdaq - US7194051022 - Common Stock - Currency: USD
PLAB gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. PLAB has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. PLAB may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, PLAB could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
PLAB had positive earnings in the past year.
In the past year PLAB had a positive cash flow from operations.
PLAB had positive earnings in each of the past 5 years.
In the past 5 years PLAB always reported a positive cash flow from operatings.
1.2 Ratios
PLAB's Return On Assets of 8.64% is fine compared to the rest of the industry. PLAB outperforms 76.36% of its industry peers.
Looking at the Return On Equity, with a value of 13.07%, PLAB is in the better half of the industry, outperforming 75.45% of the companies in the same industry.
PLAB's Return On Invested Capital of 10.39% is amongst the best of the industry. PLAB outperforms 80.91% of its industry peers.
PLAB had an Average Return On Invested Capital over the past 3 years of 12.91%. This is in line with the industry average of 11.19%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.64% | ||
| ROE | 13.07% | ||
| ROIC | 10.39% |
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
1.3 Margins
The Profit Margin of PLAB (17.08%) is better than 77.27% of its industry peers.
In the last couple of years the Profit Margin of PLAB has grown nicely.
PLAB has a better Operating Margin (25.06%) than 85.45% of its industry peers.
In the last couple of years the Operating Margin of PLAB has grown nicely.
With a Gross Margin value of 36.19%, PLAB is not doing good in the industry: 62.73% of the companies in the same industry are doing better.
PLAB's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.06% | ||
| PM (TTM) | 17.08% | ||
| GM | 36.19% |
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PLAB is creating some value.
PLAB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, PLAB has less shares outstanding
Compared to 1 year ago, PLAB has an improved debt to assets ratio.
2.2 Solvency
PLAB has an Altman-Z score of 3.32. This indicates that PLAB is financially healthy and has little risk of bankruptcy at the moment.
PLAB's Altman-Z score of 3.32 is in line compared to the rest of the industry. PLAB outperforms 52.73% of its industry peers.
The Debt to FCF ratio of PLAB is 0.02, which is an excellent value as it means it would take PLAB, only 0.02 years of fcf income to pay off all of its debts.
PLAB has a Debt to FCF ratio of 0.02. This is amongst the best in the industry. PLAB outperforms 87.27% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that PLAB is not too dependend on debt financing.
The Debt to Equity ratio of PLAB (0.00) is better than 71.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.02 | ||
| Altman-Z | 3.32 |
ROIC/WACC1.1
WACC9.49%
2.3 Liquidity
PLAB has a Current Ratio of 5.66. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.66, PLAB belongs to the best of the industry, outperforming 80.91% of the companies in the same industry.
PLAB has a Quick Ratio of 5.31. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
PLAB has a better Quick ratio (5.31) than 86.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.66 | ||
| Quick Ratio | 5.31 |
3. Growth
3.1 Past
The earnings per share for PLAB have decreased by -6.73% in the last year.
PLAB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 33.90% yearly.
PLAB shows a decrease in Revenue. In the last year, the revenue decreased by -3.85%.
PLAB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.50% yearly.
EPS 1Y (TTM)-6.73%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%23.81%
Revenue 1Y (TTM)-3.85%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-1.94%
3.2 Future
Based on estimates for the next years, PLAB will show a small growth in Earnings Per Share. The EPS will grow by 7.54% on average per year.
Based on estimates for the next years, PLAB will show a small growth in Revenue. The Revenue will grow by 3.81% on average per year.
EPS Next Y5.09%
EPS Next 2Y7.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.13%
Revenue Next 2Y3.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.18, the valuation of PLAB can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 94.55% of the companies listed in the same industry.
PLAB's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.10.
The Price/Forward Earnings ratio is 8.34, which indicates a very decent valuation of PLAB.
96.36% of the companies in the same industry are more expensive than PLAB, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.74. PLAB is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.18 | ||
| Fwd PE | 8.34 |
4.2 Price Multiples
98.18% of the companies in the same industry are more expensive than PLAB, based on the Enterprise Value to EBITDA ratio.
99.09% of the companies in the same industry are more expensive than PLAB, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.91 | ||
| EV/EBITDA | 1.92 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of PLAB may justify a higher PE ratio.
PEG (NY)1.8
PEG (5Y)0.27
EPS Next 2Y7.54%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for PLAB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
19.09
-0.13 (-0.68%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners93.24%
Inst Owner Change-1.33%
Ins Owners3.79%
Ins Owner Change5%
Market Cap1.21B
Analysts85
Price Target36.21 (89.68%)
Short Float %5.52%
Short Ratio4.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.85%
Min EPS beat(2)8.47%
Max EPS beat(2)11.24%
EPS beat(4)2
Avg EPS beat(4)-2.14%
Min EPS beat(4)-17.55%
Max EPS beat(4)11.24%
EPS beat(8)4
Avg EPS beat(8)4.24%
EPS beat(12)6
Avg EPS beat(12)4.17%
EPS beat(16)9
Avg EPS beat(16)6.19%
Revenue beat(2)1
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.96%
Max Revenue beat(2)0.12%
Revenue beat(4)1
Avg Revenue beat(4)-4.2%
Min Revenue beat(4)-8.07%
Max Revenue beat(4)0.12%
Revenue beat(8)2
Avg Revenue beat(8)-2.34%
Revenue beat(12)5
Avg Revenue beat(12)-0.89%
Revenue beat(16)7
Avg Revenue beat(16)-0.57%
PT rev (1m)1.43%
PT rev (3m)1.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.73%
EPS NY rev (1m)2%
EPS NY rev (3m)-2.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.18 | ||
| Fwd PE | 8.34 | ||
| P/S | 1.41 | ||
| P/FCF | 6.91 | ||
| P/OCF | 4.07 | ||
| P/B | 1.08 | ||
| P/tB | 1.08 | ||
| EV/EBITDA | 1.92 |
EPS(TTM)2.08
EY10.9%
EPS(NY)2.29
Fwd EY12%
FCF(TTM)2.76
FCFY14.46%
OCF(TTM)4.69
OCFY24.59%
SpS13.57
BVpS17.74
TBVpS17.74
PEG (NY)1.8
PEG (5Y)0.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.64% | ||
| ROE | 13.07% | ||
| ROCE | 14.02% | ||
| ROIC | 10.39% | ||
| ROICexc | 17.81% | ||
| ROICexgc | 17.81% | ||
| OM | 25.06% | ||
| PM (TTM) | 17.08% | ||
| GM | 36.19% | ||
| FCFM | 20.34% |
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
ROICexc(3y)20.57%
ROICexc(5y)15.24%
ROICexgc(3y)20.57%
ROICexgc(5y)15.24%
ROCE(3y)17.42%
ROCE(5y)13.37%
ROICexcg growth 3Y30.41%
ROICexcg growth 5Y29.52%
ROICexc growth 3Y30.45%
ROICexc growth 5Y29.79%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
F-Score5
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.02 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 148.28% | ||
| Cap/Sales | 14.25% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 99.77% | ||
| Profit Quality | 119.09% | ||
| Current Ratio | 5.66 | ||
| Quick Ratio | 5.31 | ||
| Altman-Z | 3.32 |
F-Score5
WACC9.49%
ROIC/WACC1.1
Cap/Depr(3y)153.58%
Cap/Depr(5y)131.47%
Cap/Sales(3y)14.5%
Cap/Sales(5y)14.32%
Profit Quality(3y)124.28%
Profit Quality(5y)132.15%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.73%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%23.81%
EPS Next Y5.09%
EPS Next 2Y7.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.85%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-1.94%
Revenue Next Year1.13%
Revenue Next 2Y3.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.07%
EBIT growth 3Y32.79%
EBIT growth 5Y33.57%
EBIT Next Year34.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.1%
FCF growth 3Y46.47%
FCF growth 5YN/A
OCF growth 1Y22.4%
OCF growth 3Y20.13%
OCF growth 5Y30.76%